SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-055650
Filing Date
2018-10-29
Accepted
2018-10-29 06:06:14
Documents
39
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv505023_10q.htm 10-Q 306101
2 EXHIBIT 31.1 tv505023_ex31-1.htm EX-31.1 7256
3 EXHIBIT 31.2 tv505023_ex31-2.htm EX-31.2 7254
4 EXHIBIT 32.1 tv505023_ex32-1.htm EX-32.1 3894
5 EXHIBIT 32.2 tv505023_ex32-2.htm EX-32.2 3896
  Complete submission text file 0001144204-18-055650.txt   2207655

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcli-20180930.xml EX-101.INS 439904
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20180930.xsd EX-101.SCH 23583
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20180930_cal.xml EX-101.CAL 19306
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20180930_def.xml EX-101.DEF 135545
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20180930_lab.xml EX-101.LAB 183803
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20180930_pre.xml EX-101.PRE 153335
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 181142710
SIC: 2836 Biological Products, (No Diagnostic Substances)